Abstrait

Percutaneous transcatheter pulmonary and tricuspid replacement in carcinoid heart disease.

Sheng Wang*

The most successful treatment for carcinoid heart disease is surgical valve replacement; however, reoperation for prosthetic valve failure has a high risk. In a patient with carcinoid heart disease, we present the first known percutaneous transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration for any reason